Biocept Inc (NASDAQ:BIOC) (FRA:B002) has reached an agreement with Health Net Federal Services, making the firm an in-network provider of the company’s Target Selector liquid biopsy oncology platform.
Health Net provides healthcare services to the TRICARE West (TriWest) regional network, which consists of roughly 3 million US military members and their families. Coverage is available in 21 states.
"It's an honor to become a provider for TriWest and to support the healthcare needs of our country's military service members and their families," CEO Michael Nall, President said in a statement. "Our Target Selector platform can be used to improve treatment outcomes by helping physicians rapidly obtain the actionable information they need to design personalized treatment plans for their patients diagnosed with cancer.
Biocept has made expanding its network a priority.
“Expanding the number of managed care agreements is among our strategic objectives. Our liquid biopsy platform is available on an in-network basis to millions of patients across the U.S. and now we are very proud to include those who are serving our country as they fight a new battle, this time with cancer."
Biocept is a diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. It has recently added coronavirus (COVID-19) testing to support efforts to fight the pandemic.
Contact Andrew Kessel at email@example.com
Follow him on Twitter @andrew_kessel